Credit Suisse Ag Bridge Bio Pharma, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 100,354 shares of BBIO stock, worth $2.86 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

100,354

Previous 90,956 10.33%

Holding current value

$2.86 Million

Previous $3.67 Million 15.5%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$27.35 - $40.45 $257,035 - $380,149	9,398 Added 10.33%	100,354 $3.1 Million
Q4 2023 Feb 08, 2024	SELL	$24.02 - $43.89 $15.2 Million - $27.7 Million	-631,783 Reduced 87.42%	90,956 $3.67 Million
Q3 2023 Nov 13, 2023	SELL	$16.89 - $35.01 $777,058 - $1.61 Million	-46,007 Reduced 5.98%	722,739 $19.1 Million
Q2 2023 Aug 11, 2023	BUY	$13.29 - $18.01 $477,350 - $646,883	35,918 Added 4.9%	768,746 $13.2 Million
Q1 2023 May 10, 2023	BUY	$7.17 - $18.55 $1.54 Million - $3.98 Million	214,727 Added 41.45%	732,828 $12.2 Million
Q4 2022 Feb 13, 2023	SELL	$6.74 - $11.52 $612,847 - $1.05 Million	-90,927 Reduced 14.93%	518,101 $3.95 Million
Q3 2022 Nov 10, 2022	BUY	$7.94 - $12.36 $289,476 - $450,620	36,458 Added 6.37%	609,028 $6.05 Million
Q2 2022 Aug 12, 2022	SELL	$5.21 - $12.14 $223,795 - $521,473	-42,955 Reduced 6.98%	572,570 $5.2 Million
Q1 2022 May 16, 2022	SELL	$7.34 - $17.16 $397,908 - $930,260	-54,211 Reduced 8.09%	615,525 $6.25 Million
Q4 2021 Feb 14, 2022	BUY	$11.38 - $53.41 $2.31 Million - $10.8 Million	202,610 Added 43.37%	669,736 $11.2 Million
Q3 2021 Nov 12, 2021	BUY	$46.87 - $64.24 $3.52 Million - $4.83 Million	75,118 Added 19.16%	467,126 $21.9 Million
Q2 2021 Aug 16, 2021	BUY	$46.47 - $63.93 $1.16 Million - $1.6 Million	25,029 Added 6.82%	392,008 $23.9 Million
Q1 2021 May 14, 2021	BUY	$55.47 - $72.35 $1.55 Million - $2.02 Million	27,919 Added 8.23%	366,979 $22.6 Million
Q4 2020 Feb 12, 2021	SELL	$38.38 - $71.11 $4.72 Million - $8.75 Million	-123,027 Reduced 26.62%	339,060 $24.1 Million
Q3 2020 Nov 13, 2020	SELL	$27.2 - $42.19 $2.31 Million - $3.58 Million	-84,914 Reduced 15.52%	462,087 $17.3 Million
Q2 2020 Aug 12, 2020	BUY	$22.22 - $35.69 $11.9 Million - $19.2 Million	536,945 Added 5339.55%	547,001 $17.8 Million
Q1 2020 May 13, 2020	SELL	$16.11 - $36.23 $196,155 - $441,136	-12,176 Reduced 54.77%	10,056 $292,000
Q4 2019 Feb 12, 2020	BUY	$17.96 - $46.63 $399,286 - $1.04 Million	22,232 New	22,232 $780,000
Q3 2019 Nov 12, 2019	SELL	$20.13 - $32.38 $523,380 - $841,880	-26,000 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$26.97 - $27.55 $701,220 - $716,300	26,000 New	26,000 $701,000

Others Institutions Holding BBIO

# of Institutions

290

Shares Held

170M

Call Options Held

10.4M

Put Options Held

2.37M

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $4.23B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account